Last reviewed · How we verify

NCT04552912: Build Stamina

Physical Activity to Improve Patient Reported Outcomes for Adults With Acute Leukemia

Completed NA Last updated 23 September 2022
What this trial tests

NA trial testing Build Stamina Program in Physical Activity in 49 participants. Completed in 15 September 2022.

Timeline
15 January 2021
Primary endpoint
15 September 2022
15 September 2022

Quick facts

Lead sponsorDuke University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment49
Start date15 January 2021
Primary completion15 September 2022
Estimated completion15 September 2022
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Duke University

Who can join

18 and older, any sex, with Physical Activity or Exercise. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to test the efficacy of an evidence-based tailored physical activity program adapted for adults with acute leukemia. Implementation-related process evaluation of the physical activity program will also be assessed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

Other Duke University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04552912.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing